Equities
Consumer ServicesFood & Drug Retailers
  • Price (USD)138.23
  • Today's Change-1.45 / -1.04%
  • Shares traded63.49k
  • 1 Year change3.30%
  • Beta1.1309
Data delayed at least 15 minutes, as of Jul 19 2019 14:53 BST.
More ▼

Profile data is unavailable for this security.

About the company

McKesson Corporation is a healthcare supply chain management solutions, retail pharmacy, community oncology and specialty care, and healthcare information technology company. The Company provides medicines, medical products and healthcare services by partnering with pharmaceutical manufacturers, providers, pharmacies, governments and other organizations in healthcare. It operates through two segments: McKesson Distribution Solutions and McKesson Technology Solutions. The distribution solutions segment distributes branded and generic pharmaceutical drugs and other healthcare-related products internationally and provides practice management, technology, clinical support and business solutions to community-based oncology and other specialty practices. Technology Solutions segment provides software and analytics, network solutions and technology-enabled services.

  • Revenue in USD (TTM)214.32bn
  • Net income in USD-53.00m
  • Incorporated1994
  • Employees80.00k
  • Location
    McKesson Corp1 Post StSAN FRANCISCO 94104-5203United StatesUSA
  • Phone+1 (415) 983-8300
  • Fax+1 (302) 636-5454
  • Websitehttp://www.mckesson.com
More ▼

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
Cardinal Health Inc143.53bn19.00m13.47bn50.20k298.222.1613.040.09380.15150.0999472.5320.913.5111.1218.462,859,163.000.05132.730.11516.294.805.350.01460.76710.54185.780.59358.285.266.24-149.61--14.5112.53
BioMarin Pharmaceutical Inc.1.52bn-89.54m14.90bn2.85k--5.072,692.389.81-0.5033-0.50338.5516.400.33630.64244.27532,997.60-1.98-5.98-2.31-6.8478.7981.28-5.90-19.562.76--0.2237--13.5222.14-3.30--17.28--
EXACT Sciences Corporation526.21m-218.78m15.10bn1.98k--19.42--28.69-1.76-1.764.266.020.34763.6111.61266,165.40-14.45-33.75-15.70-36.9473.7168.50-41.58-97.508.13-6.810.5058--70.86155.8726.81--76.69--
Incyte Corporation2.00bn252.95m17.44bn1.37k69.518.3656.548.731.171.179.259.730.789513.118.601,461,198.0010.00-1.9111.73-2.3396.1496.4412.66-2.445.217.820.0091--22.5039.60134.97--76.69--
AmerisourceBergen Corp.175.15bn867.88m18.23bn21.00k21.686.2413.230.10414.004.29810.1913.904.5414.0514.328,340,548.002.152.008.468.552.782.730.47370.40630.556211.160.604547.299.6613.81186.9316.2110.6912.59
McKesson Corporation214.32bn-53.00m26.03bn80.00k--3.2823.310.1215-0.41060.041,090.6842.603.5712.2711.922,678,988.000.27993.150.79168.615.485.750.07840.91350.57829.760.439715.382.869.3093.42--6.0610.66
Iqvia Holdings Inc10.53bn213.00m31.02bn58.00k151.704.6922.322.951.041.2151.2333.540.4546--4.47181,603.501.022.151.212.6635.0432.042.243.61--1.960.62180.007.3215.35-27.97-0.229839.04--
Regeneron Pharmaceuticals Inc6.91bn2.36bn32.65bn7.40k14.763.5212.944.7220.5421.1360.1386.190.62190.633.25933,934.4021.2317.7424.2620.7593.4292.9134.1423.684.03--0.06990.0014.2826.1055.8641.1419.63--
Data as of Jul 19 2019. Currency figures normalised to McKesson Corp's reporting currency: US Dollar USD

Institutional shareholders

37.54%Per cent of shares held by top holders
HolderShares% Held
The Vanguard Group, Inc.as of 31 Mar 201916.02m8.59%
SSgA Funds Management, Inc.as of 31 Mar 20199.07m4.87%
BlackRock Fund Advisorsas of 31 Mar 20198.91m4.78%
Wellington Management Co. LLPas of 31 Mar 20197.89m4.23%
Massachusetts Financial Services Co.as of 31 Mar 20195.86m3.14%
Glenview Capital Management LLCas of 31 Mar 20194.92m2.64%
Boston Partners Global Investors, Inc.as of 31 Mar 20194.76m2.56%
Invesco Advisers, Inc.as of 31 Mar 20194.38m2.35%
Vulcan Value Partners LLCas of 31 Mar 20194.22m2.26%
Fidelity Management & Research Co.as of 31 Mar 20193.95m2.12%
More ▼
Data from 31 Mar 2019 - 31 Mar 2019Source: FactSet Research Systems Inc.
The Financial and Risk business of Thomson Reuters is now Refinitiv
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.